Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZEAL | AMGN | GILD | CELG | ILMN |
| Company | Zealand Pharma A/S ADR | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.03 | 308.00 | 65.33 | 108.01 | 109.80 |
| High | 18.07 | 308.00 | 65.33 | 108.59 | 109.80 |
| Low | 17.47 | 308.00 | 65.33 | 107.27 | 109.80 |
| Last | 17.59 | 308.00 | 65.33 | 108.24 | 109.80 |
| Change | +0.21 | +0.69 | +0.41 | +0.11 | -0.82 |
| % Change | +1.21% | +0.22% | +0.63% | +0.10% | -0.74% |
| Volume | 2,100 | 1,155 | 11,800 | 191,230,496 | 707 |
| 20-Day Average Volume | 2,250 | 2,761,268 | 7,160,465 | 16,188,930 | 1,560,380 |
| Previous Close | 17.38 | 307.31 | 64.92 | 108.13 | 110.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.09 | 279.22 | 66.14 | 108.17 | 119.79 |
| 20-Day Raw Stochastic | 27.14% | 76.42% | 23.31% | 63.25% | 4.79% |
| 20-Day Relative Strength | 50.34% | 66.21% | 35.30% | 64.69% | 34.40% |
| Weighted Alpha | -38.80 | +32.74 | -20.35 | +46.30 | -46.13 |
| Today's Opinion | 48% Buy | 56% Buy | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 32% Buy | 56% Buy | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 24% Buy | 40% Sell | 100% Sell | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.11% since 09/21/22 | +10.64% since 05/02/24 | unch since 05/02/24 | -1.97% since 11/13/19 | -11.44% since 05/02/24 |
| Low | 16.54 on 09/27/22 | 297.52 on 05/06/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 108.54 on 05/08/24 |
| High | 18.07 on 09/29/22 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 127.89 on 05/03/24 |
| 1-Month | |||||
| %Chg | +2.45% since 08/29/22 | +13.92% since 04/09/24 | -6.59% since 04/09/24 | +5.14% since 10/18/19 | -17.80% since 04/09/24 |
| Low | 16.51 on 09/19/22 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 108.54 on 05/08/24 |
| High | 20.03 on 09/09/22 | 322.60 on 05/03/24 | 69.76 on 04/10/24 | 110.70 on 11/13/19 | 134.85 on 04/12/24 |
| 3-Month | |||||
| %Chg | +32.96% since 06/29/22 | +5.80% since 02/09/24 | -11.32% since 02/09/24 | +13.63% since 08/20/19 | -20.34% since 02/09/24 |
| Low | 12.82 on 07/01/22 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 108.54 on 05/08/24 |
| High | 20.49 on 08/25/22 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 147.25 on 02/16/24 |
| 6-Month | |||||
| %Chg | +20.23% since 03/29/22 | +16.64% since 11/09/23 | -12.87% since 11/09/23 | +14.14% since 05/20/19 | +2.64% since 11/09/23 |
| Low | 9.93 on 05/16/22 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 20.49 on 08/25/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 818,603 | 164,851,840 | 80,830,400 | 77,035,920 | 17,621,766 |
| Shares Outstanding, K | 46,538 | 536,435 | 1,245,077 | 711,714 | 159,300 |
| Annual Sales | 46,550,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -161,990,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 4,060,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 1,076,000,000 |
| Last Quarter Net Income | -69,960,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | -126,000,000 |
| 60-Month Beta | 1.45 | 0.60 | 0.22 | 1.41 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.40 on 08/11/22 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.09 on 05/02/24 |
| Latest Earnings Date | 11/10/22 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.12 | 16.24 | 10.99 | 128.20 |